COVID-19 Research Guide

See a list of other guidelines at end of page.

American Thoracic Society Guideines. 2017

The American Thoracic Society and
Infectious Diseases Society of America

For the evaluation of patients who may be ill with or who may have been
exposed to 2019 Novel Coronavirus (2019-nCoV)

Features case count by country, nomenclature and characterization, transmission and clinical features. gov.UK

International, United States, U.K., Canadian, European, Asian, Austrialian and New Zealand Source: DynaMed

Clinical Presentation, Clinical Course, Diagnostic Testing, Laboratory and Radiographic Findings and Clinical Management and Treatment. CDC

Has a clinical decision support tool, news, a timeline of the coronavirus outbreak, clinical update,

Fast, evidence-based answers to your clinical questions at the point of care.The week of February 3, 2020 there will be free content addressing symptoms, identification, and courses of action.

Clinical studies related to the novel coronavirus. ClinicalTrials.gov

Recommendations for Reporting, Testing, and Specimen Collection, Interim Healthcare Infection Prevention and Control Recommendations for Patients Under Investigation for 2019-nCoV. CDC

Contains Criteria to Guide Evaluation of Patients Under Investigation (PUI) for 2019-nCoV. CDC

This interim guidance is for staff at local and state health departments, infection prevention and control professionals, and healthcare personnel who are coordinating the home care and isolation1 of people with confirmed or suspected 2019-nCoV infection, including patients under investigation.CDC

This guidance is based on the currently limited information available about 2019-nCoV related to disease severity, transmission efficiency, and shedding duration. CDC

Contains epidemiology, etiology and pathogenesis, history and physical, diagnosis, management, infection control, guidelines and resources and patient information.

Epidemiology, etiology, diagnosis, management, prevention and prognosis with references.

Includes reviews that are relevant to the WHO interim guidance, those identified as relevant by Cochrane Acute and Emergency Care, and also draws on the knowledge of Cochrane groups in affected regions.